MX2020013389A - Composiciones de terlipresina y usos de las mismas. - Google Patents
Composiciones de terlipresina y usos de las mismas.Info
- Publication number
- MX2020013389A MX2020013389A MX2020013389A MX2020013389A MX2020013389A MX 2020013389 A MX2020013389 A MX 2020013389A MX 2020013389 A MX2020013389 A MX 2020013389A MX 2020013389 A MX2020013389 A MX 2020013389A MX 2020013389 A MX2020013389 A MX 2020013389A
- Authority
- MX
- Mexico
- Prior art keywords
- terlipressin
- compositions
- terlipressin compositions
- pharmaceutical compositions
- therapeutic methods
- Prior art date
Links
- 108010010056 Terlipressin Proteins 0.000 title abstract 2
- BENFXAYNYRLAIU-QSVFAHTRSA-N terlipressin Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CN)CSSC1 BENFXAYNYRLAIU-QSVFAHTRSA-N 0.000 title abstract 2
- 229960003813 terlipressin Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862685447P | 2018-06-15 | 2018-06-15 | |
| PCT/IB2019/055004 WO2019239386A1 (en) | 2018-06-15 | 2019-06-14 | Terlipressin compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020013389A true MX2020013389A (es) | 2021-03-31 |
Family
ID=67742882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020013389A MX2020013389A (es) | 2018-06-15 | 2019-06-14 | Composiciones de terlipresina y usos de las mismas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11931398B2 (https=) |
| EP (1) | EP3806823A1 (https=) |
| JP (2) | JP7523775B2 (https=) |
| CN (1) | CN112969449B (https=) |
| BR (1) | BR112020025380A2 (https=) |
| CA (1) | CA3103215A1 (https=) |
| MX (1) | MX2020013389A (https=) |
| TW (1) | TW202003548A (https=) |
| WO (1) | WO2019239386A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220080023A1 (en) * | 2018-12-21 | 2022-03-17 | Arecor Limited | Novel composition |
| KR20220011697A (ko) | 2019-05-22 | 2022-01-28 | 바이오비에 아이앤씨. | 테를리프레신 제형 |
| CN114177147B (zh) * | 2021-12-15 | 2023-05-23 | 福建省闽东力捷迅药业股份有限公司 | 一种注射用特利加压素的制备方法以及制得的注射用特利加压素 |
| US20240156895A1 (en) * | 2022-10-28 | 2024-05-16 | Mallinckrodt Pharmaceuticals Ireland Limited | Compositions for improving kidney function in patients with hepatorenal syndrome |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
| CN1244794A (zh) * | 1997-11-06 | 2000-02-16 | 奥尔班公司 | 用于药物释放的稳定的干燥药物组合物及其制备方法 |
| RU2415149C2 (ru) * | 2006-02-10 | 2011-03-27 | Ферринг Б.В. | Пептидные соединения |
| CN102068685A (zh) * | 2010-04-09 | 2011-05-25 | 深圳翰宇药业股份有限公司 | 一种特利加压素制剂及其制备方法 |
| CN102440957B (zh) | 2011-12-16 | 2013-09-25 | 深圳市健元医药科技有限公司 | 醋酸特利加压素鼻腔喷雾剂及其制备方法 |
| CN104334117A (zh) | 2012-01-26 | 2015-02-04 | 恩多沙普公司 | 用远端和/或近端控制来输送管腔闭塞装置的系统、装置和方法 |
| AR091902A1 (es) * | 2012-07-25 | 2015-03-11 | Hanmi Pharm Ind Co Ltd | Formulacion liquida de un conjugado de insulina de accion prolongada |
| CN105592855A (zh) * | 2013-04-26 | 2016-05-18 | 拉卓拉药物公司 | 用于治疗肾衰竭的组合物和方法 |
| US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| CN106188218B (zh) * | 2016-07-14 | 2018-11-23 | 江苏诺泰澳赛诺生物制药股份有限公司 | 一种提高多肽原料药稳定性的方法 |
| GB201721846D0 (en) | 2017-12-22 | 2018-02-07 | Arecor Ltd | Novel composition |
| KR20220011697A (ko) | 2019-05-22 | 2022-01-28 | 바이오비에 아이앤씨. | 테를리프레신 제형 |
-
2019
- 2019-06-14 JP JP2020568956A patent/JP7523775B2/ja active Active
- 2019-06-14 MX MX2020013389A patent/MX2020013389A/es unknown
- 2019-06-14 TW TW108120774A patent/TW202003548A/zh unknown
- 2019-06-14 WO PCT/IB2019/055004 patent/WO2019239386A1/en not_active Ceased
- 2019-06-14 EP EP19758802.3A patent/EP3806823A1/en active Pending
- 2019-06-14 CA CA3103215A patent/CA3103215A1/en active Pending
- 2019-06-14 CN CN201980053281.8A patent/CN112969449B/zh active Active
- 2019-06-14 BR BR112020025380-4A patent/BR112020025380A2/pt unknown
- 2019-06-14 US US17/252,153 patent/US11931398B2/en active Active
-
2024
- 2024-04-15 JP JP2024065219A patent/JP2024086898A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210161995A1 (en) | 2021-06-03 |
| JP2024086898A (ja) | 2024-06-28 |
| US11931398B2 (en) | 2024-03-19 |
| CN112969449B (zh) | 2025-03-11 |
| CN112969449A (zh) | 2021-06-15 |
| JP7523775B2 (ja) | 2024-07-29 |
| EP3806823A1 (en) | 2021-04-21 |
| WO2019239386A1 (en) | 2019-12-19 |
| JP2021527084A (ja) | 2021-10-11 |
| TW202003548A (zh) | 2020-01-16 |
| BR112020025380A2 (pt) | 2021-05-18 |
| CA3103215A1 (en) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025003235A (es) | Composiciones y metodos para el suministro de proteinas de membrana | |
| PH12020551716A1 (en) | Anti-ror antibody constructs | |
| IL276464A (en) | Methods and preparations for administering therapeutic protein | |
| EP4620519A3 (en) | Methods and compositions relating to chondrisomes from blood products | |
| MX2022004304A (es) | Agentes inductores de apoptosis. | |
| MX2023011657A (es) | Composiciones que comprenden curones y usos de los mismos. | |
| MX2024004386A (es) | Dianas terapeuticas para la correccion del gen de la distrofina humana por edicion genica y metodos de uso. | |
| PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| MY191581A (en) | Anti-pd-1 antibodies | |
| SA518391831B1 (ar) | تركيبات وطرق لخفض تعبير البروتين تاو | |
| GB2541571A (en) | Pharmaceutical compositions | |
| MX2017011997A (es) | Carbamatos de piperacina y metodos de preparacion y uso. | |
| MX2025010681A (es) | Formulaciones transdermicas | |
| EP4599893A3 (en) | Cg0070 for treating bcg resistant bladder carcinoma in situ | |
| ZA201807438B (en) | Methods of treating ocular conditions | |
| WO2018226992A8 (en) | Tau aggregation inhibitors | |
| MX2020013389A (es) | Composiciones de terlipresina y usos de las mismas. | |
| MX387731B (es) | Composiciones farmacéuticas orales de mesalazina. | |
| PH12017500602A1 (en) | Methods for treating ocular conditions | |
| EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
| JOP20190164B1 (ar) | تركيبات وطرق لعلاج داء فاربر | |
| PH12020551618A1 (en) | Erenumab compositions and uses thereof | |
| MA40642A (fr) | Nouveaux dérivés peptidiques et leurs utilisations | |
| MX2019014475A (es) | Formulaciones de lixivaptan para el tratamiento de enfermedades poliquisticas. | |
| HK40042312A (en) | Methods and compositions for therapeutic protein delivery |